Pipeline Programs↗
Distinct drugs in development (Preclinical–Phase 3)
Indications↗
Distinct diseases across all programs
Clinical Trials↗
All sponsored trials (all statuses)
Pipeline
By Phase
13 drugs in development
By Therapeutic Area
top 6
R&D Momentum
100/100
Pipeline Velocity
94/100
Trial Completion Rate
82/100
Pipeline Concentration
25/100
Pipeline Freshness
78/100
Strategic Signals
Activity
Last 14 days
CSP #2038 - COVID-19 Pharmacotherapy Effectiveness in the VA Healthcare System (COPE-VA)
Transcutaneous Vagal Nerve Stimulation in Veterans With Posttraumatic Stress Disorder
Pathways to Hope: Pilot fMRI Study of OCPD and Suicide Risk in Trauma-Exposed Veterans
CSP #2019 - Basal Cell Carcinoma Chemoprevention Trial (B3C)
Non-Invasive Vagal Nerve Stimulation in Veterans With Mild Traumatic Brain Injury (mTBI)
Reducing Veterans' Risk of Atherosclerotic Cardiovascular Disease Through Pharmacogenomics Informed Statin Prescribing
Passive Limb Movement: A Tool to Assess Vascular Health and Guide Rehabilitation
Benefit of Venetoclax Addition ("Benefit VA") in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)
Brain Targets for Alcohol Craving in Veterans With mTBI
Details
Company Overview
—
Mkt Cap
—
Revenue
—
Cash
Pipeline
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)